Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

512600

ASTALLTD

img img img img
No Data Available

ASTAL LABORATORIES LIMITED Share Price Update

As of the latest trading session, ASTAL LABORATORIES LIMITED share price is currently at ₹ 82.99, which is down by ₹ -0.06 from its previous closing. Today, the stock has fluctuated between ₹ 80.05 and ₹ 84.74. Over the past year, ASTAL LABORATORIES LIMITED has achieved a return of -4.26 %. In the last month alone, the return has been -9.68 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ASTAL LABORATORIES LIMITED fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    342.10

  • P/E Ratio (TTM)

    34.48

  • Beta

    0.60

  • Book Value / share

    76.88

  • Return on equity

    30.10%

  • EPS (TTM)

    2.35

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    2.58

info icon alternate text

ASTAL LABORATORIES LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 37.52
Operating Expense 34.08
Net Profit 2.58
Net Profit Margin (%) 6.87
Earnings Per Share (EPS) 2.40
EBITDA 3.90
Effective Tax Rate (%) 25.64
Particulars JUN 2025 (Values in Cr)
Revenue 25.33
Operating Expense 22.59
Net Profit 2.09
Net Profit Margin (%) 8.25
Earnings Per Share (EPS) 2.13
EBITDA 3.21
Effective Tax Rate (%) 25.08
Particulars MAR 2025 (Values in Cr)
Revenue 23.47
Operating Expense 19.66
Net Profit 2.74
Net Profit Margin (%) 11.67
Earnings Per Share (EPS) 2.80
EBITDA 4.22
Effective Tax Rate (%) 28.57
Particulars DEC 2024 (Values in Cr)
Revenue 14.46
Operating Expense 11.50
Net Profit 2.49
Net Profit Margin (%) 17.21
Earnings Per Share (EPS) 2.53
EBITDA 3.38
Effective Tax Rate (%) 17.54
Particulars SEP 2024 (Values in Cr)
Revenue 13.16
Operating Expense 10.39
Net Profit 2.00
Net Profit Margin (%) 15.19
Earnings Per Share (EPS) 2.04
EBITDA 2.88
Effective Tax Rate (%) 27.79
Particulars MAR 2025 (Values in Cr)
Revenue 64.23
Operating Expense 52.38
Net Profit 8.93
Net Profit Margin (%) 13.90
Earnings Per Share (EPS) 9.08
EBITDA 12.90
Effective Tax Rate (%) 25.45
Particulars MAR 2024 (Values in Cr)
Revenue 23.65
Operating Expense 22.57
Net Profit 0.78
Net Profit Margin (%) 3.29
Earnings Per Share (EPS) 0.80
EBITDA 1.13
Effective Tax Rate (%) 27.52
Particulars MAR 2023 (Values in Cr)
Revenue 3.43
Operating Expense 3.57
Net Profit 0.02
Net Profit Margin (%) 0.58
Earnings Per Share (EPS) 0.04
EBITDA 0.04
Effective Tax Rate (%) 66.66
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.23
Net Profit -0.02
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.04
EBITDA -0.01
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.20
Net Profit 0.01
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.02
EBITDA 0.03
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 32.77
ROE % 30.10
ROCE % 34.78
Total Debt to Total Equity 0.23
EBITDA Margin 20.08
Particulars MAR 2024 (Values in Cr)
Book Value / Share 23.71
ROE % 5.47
ROCE % 7.56
Total Debt to Total Equity 0.01
EBITDA Margin 4.78
Particulars MAR 2023 (Values in Cr)
Book Value / Share 12.98
ROE % 0.39
ROCE % 0.77
Total Debt to Total Equity 0.00
EBITDA Margin 1.17
Particulars MAR 2022 (Values in Cr)
Book Value / Share 12.93
ROE % -0.39
ROCE % -0.19
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 12.97
ROE % 0.19
ROCE % 0.19
Total Debt to Total Equity 0.00
EBITDA Margin 10.00
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.73
Total Assets 63.34
Total Liabilities 63.34
Total Equity 35.99
Share Outstanding 9830100
Price to Book Ratio 2.32
Return on Assets (%) 14.09
Return on Capital (%) 18.12
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 6.07
Total Assets 36.61
Total Liabilities 36.61
Total Equity 23.33
Share Outstanding 9830100
Price to Book Ratio 1.72
Return on Assets (%) 2.14
Return on Capital (%) 3.32
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 9.90
Total Liabilities 9.90
Total Equity 5.17
Share Outstanding 3974070
Price to Book Ratio 2.28
Return on Assets (%) 0.16
Return on Capital (%) 0.32
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 5.22
Total Liabilities 5.22
Total Equity 5.16
Share Outstanding 3974070
Price to Book Ratio 1.25
Return on Assets (%) -0.32
Return on Capital (%) -0.33
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 5.30
Total Liabilities 5.30
Total Equity 5.17
Share Outstanding 3974070
Price to Book Ratio 0.67
Return on Assets (%) 0.11
Return on Capital (%) 0.12
Particulars MAR 2025 (Values in Cr)
Net Income 11.97
Cash from Operations -12.21
Cash from Investing -7.81
Cash from Financing 3.29
Net change in Cash -17.04
Free Cash Flow -6.44
Particulars MAR 2024 (Values in Cr)
Net Income 1.08
Cash from Operations -5.54
Cash from Investing -6.10
Cash from Financing 17.67
Net change in Cash 5.99
Free Cash Flow 0.36
Particulars MAR 2023 (Values in Cr)
Net Income 0.03
Cash from Operations -1.42
Cash from Investing 1.50
Cash from Financing 0.00
Net change in Cash 0.06
Free Cash Flow -1.42
Particulars MAR 2022 (Values in Cr)
Net Income -0.01
Cash from Operations -0.24
Cash from Investing 0.23
Cash from Financing 0.00
Net change in Cash -0.01
Free Cash Flow -0.24
Particulars MAR 2021 (Values in Cr)
Net Income 0.00
Cash from Operations -0.18
Cash from Investing 0.20
Cash from Financing 0.00
Net change in Cash 0.01
Free Cash Flow -0.18
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 25.01 12.26 1.29 191.66 24.01 / 53.83
BLISS GVS PHARMA LTD 161.95 15.63 1.51 1713.25 105.05 / 195.85
CIPLA LTD 1314.85 22.34 3.22 106209.80 1303.80 / 1672.20
FERMENTA BIOTECH LIMITED 311.30 8.18 2.34 916.19 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2311.50 41.08 22.93 39158.20 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 25.01 20.33 3.48 191.66 24.01 / 53.83
AMRUTAJAN HEALTH LTD 606.10 30.91 5.12 1752.27 548.05 / 789.95
ASTRAZENECA PHARMA IND LT 8305.85 89.82 25.98 20764.63 6501.60 / 10653.05
BLISS GVS PHARMA LTD 161.95 21.86 1.55 1713.25 105.05 / 195.85

ASTAL LABORATORIES LIMITED shareholding pattern

Holding

95.35%
4.64%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

ASTAL LABORATORIES LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
81.03 -2.43 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 82.90
  • 26 Days 85.00
  • 10 Days 83.70
  • 50 Days 86.30
  • 12 Days 84.00
  • 100 Days 87.30
  • 20 Days 84.60
  • 200 Days 85.80
84.48 PIVOT

First Support

81.57

First Resistance

85.96

Second Support

80.09

Second Resistance

88.87

Third Support

77.18

Third Resistance

90.35

RSI

42.27

ADX

11.81

MACD

-1.05

Williams % R

-66.36

Commodity Channel Index (CCI)

-129.96

Date

2026-01-23

Week

8813.00

Same Day

16860.00

Month

10343.00

1 Year

0.60

3 Year

0.27

Over 1 Month

-9.68%

down

Over 1 Year

-4.26%

down

Over 3 Months

-19.46%

down

Over 3 Years

39.81%

down

Over 6 Months

-16.42%

down

Over 5 Years

56.07%

down

ASTAL LABORATORIES LIMITED Corporate Actions

Top Gainers

ASTAL LABORATORIES LIMITED Share Price

Astal Laboratories Limited was formerly incorporated as a public company limited by shares on August 03, 1993 in the name of Macro International Limited. The Company was taken over under SEBI takeover guidelines in 2022 and the main objects of the Company was changed to 'Manufacture and Sales of Pharmaceutical Intermediates and Bulk Drugs'. Subsequently the name of the Company was changed to Astal Laboratories Limited in May, 2024. The Company is now a subsidiary of Aceso Research Labs LLP.

The Company was promoted by the Kanpur based business house of Parasrampurias. The Company set up a departmental store at Plaza Kalpana, Birhana Road, Kanpur, offering products such as readymade garments, electronic items, leather items, stationery, books, fast food centre etc.

During 1996-97, the departmental store project succeeded, only Saree Division and Archies Card Division was in operation. The Leather Unit set up at Village Goddhroli, Distt. Fatehpur manufactured of various leather harness and sadddlery goods viz., bridles, halters, girths, martingles, stirup leather, leather reins, brow bands and saddles.

Company has ventured into the pharmaceutical bulk drug business and Key Starting Materials/ Intermediates in FY2025 to meet the growing global demand for essential pharmaceutical ingredients.

Parent organization Indian Private
NSE symbol [-]
Founded 1993
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Astal Laboratories Ltd?

Answer Field

Astal Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 81.03 as on Jan 23 2026 03:25 PM.

What is the Market Cap of Astal Laboratories Ltd Share?

Answer Field

The market cap of Astal Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 342.10 as on Jan 23 2026 03:25 PM.

What is the 52 Week High and Low of Astal Laboratories Ltd?

Answer Field

The 52 Week High and Low of Astal Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 103.20 and ₹ 72.90.

What is 1 year return for Astal Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been -4.26%.

What is the P/E Ratio of Astal Laboratories Ltd Share?

Answer Field

As on Jan 23 2026 03:25 PM the price-to-earnings (PE) ratio for Astal Laboratories Ltd share is 34.48.

What is the PB ratio of Astal Laboratories Ltd Share?

Answer Field

As on Jan 23 2026 03:25 PM, the price-to-book (PB) ratio for Astal Laboratories Ltd share is 76.88.

How to Buy Astal Laboratories Ltd Share?

Answer Field

You can trade in Astal Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Astal Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Astal Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Astal Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59